Developmental Profile of Ocular Refraction in Patients With Congenital Cataract
NCT ID: NCT02761850
Last Updated: 2016-05-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1164 participants
OBSERVATIONAL
2010-01-31
2016-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
An Interocular Comparative Study of Unilateral Cataract
NCT02765230
Validation of a Predictive Algorithm to Determine the Effectiveness of Orthokeratology for Myopia Control
NCT04275635
Development and Pathological Changes of High Myopia Among Children and Adolescents in China
NCT03533647
Ocular Development and Refractive Error Changes Among Children and Adolescent - A Longitudinal Study
NCT03589937
Comparison of the Effect of Minimal Invasive Lens Surgery and Traditional Cataract Surgery
NCT03908359
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The investigator described the developmental profile of refraction change in a large cohort of Chinese CC patients. The decisive factors to the range of myopic shift in unilateral CC appeared to be different from that in bilateral CC, indicating dramatic differences in the etiopathogenesis and refractive prognosis between bilateral and unilateral CC. The refraction data from CC patients provided in the study are of clinical significance to the guidelines for CC treatment, especially for IOL calculation concerning the laterality of CC.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Children with unilateral/bilateral cataract
Exclusion Criteria
* Lens luxation
* Glaucoma
* Retinal diseases
* Nystagmus and nanophthalmos
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ministry of Health, China
OTHER_GOV
Sun Yat-sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Haotian Lin
Principal Investigator, Home for Cataract Children, Zhongshan Ophthalmic Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Haotian Lin, M.D., Ph.D
Role: PRINCIPAL_INVESTIGATOR
Zhongshan Ophthalmic Center, Sun Yat-sen University
Yizhi Liu, M.D., Ph.D
Role: STUDY_CHAIR
Zhongshan Ophthalmic Center, Sun Yat-sen University
Weirong Chen, M.D., Ph.D
Role: STUDY_DIRECTOR
Zhongshan Ophthalmic Center, Sun Yat-sen University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Lin H, Long E, Chen W, Liu Y. Documenting rare disease data in China. Science. 2015 Sep 4;349(6252):1064. doi: 10.1126/science.349.6252.1064-b. No abstract available.
Related Links
Access external resources that provide additional context or updates about the study.
Home page of Zhongshan Ophthalmic Center
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CCPMOH2016-China-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.